Pruett, Lauren J. http://orcid.org/0000-0002-2121-1013
Kenny, Hannah L. http://orcid.org/0000-0002-2652-9418
Swift, William M. http://orcid.org/0000-0001-6146-2960
Catallo, Katarina J.
Apsel, Zoe R.
Salopek, Lisa S.
Scumpia, Philip O.
Cottler, Patrick S. http://orcid.org/0000-0002-2542-6142
Griffin, Donald R. http://orcid.org/0000-0002-3458-867X
Daniero, James J. http://orcid.org/0000-0003-3693-4617
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (1R01DK126020-01A1)
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (F31HL154731)
National Science Foundation (GRFP)
Article History
Received: 5 April 2022
Accepted: 25 January 2023
First Online: 23 February 2023
Competing interests
: D.G. has financial interests in Tempo Therapeutics which currently aims to commercialize MAP technology for wound healing applications. D.R.G., J.J.D., and L.J.P. have a non-provisional patent pending (US17/044,058) on this technology. The remaining authors declare no competing interests.